Top Story

Zeiss appoints Jim Mazzo as global president of ophthalmology

Zeiss appoints Jim Mazzo as global president of ophthalmology
July 27, 2016

Carl Zeiss Meditec appointed James V. Mazzo as global president of ophthalmology, according to a company press release.

In this role, Mazzo will be responsible for leading the new strategic business unit of ophthalmology and the company’s U.S. sales and service center.

In the Journals

Use of EHRs, CPOE associated with physician burnout, dissatisfaction

July 27, 2016
Physicians reported low satisfaction with their electronic health records and computerized physician order entry, according to findings published in Mayo Clinic
Health Care Legislative and Regulatory Update

Are the holiday baskets really worth the risk?

July 27, 2016
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
CommentaryFrom OSN APAO

Health care providers have duty to reduce impact of their work on environment

Ocular Surgery News APAO Edition, July 2016
Bhaskar Srinivasan, MD; Dennis S.C. Lam, MD, FRCOphth
Climate change is predicted to be one of the largest health threats of the 21st century. Human activities are increasing the release of greenhouse gases, leading to…
Cover StoryFrom OSN APAO

Hospital chain in India sets a model for low carbon footprint, environment-friendly cataract surgery

Ocular Surgery News APAO Edition, July 2016
Health care procedures are a large contributor to carbon emissions throughout the world. As awareness and concerns about the environmental issues related to global…
More News Headlines »
Clinical Science

Posterior Segment Distortion in Ultra-Widefield Imaging Compared to Conventional Modalities

Ophthalmic Surgery, Lasers and Imaging Retina, July 2016, Volume 47 Issue 7
To describe posterior segment distortions in Optos ultra-widefield images (Optos 200TX; Optos, Dunfermline, United…
More »

Imaging Modalities in Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Highlights from ASCRS

Highlights from ASCRS

Meeting News Coverage

VIDEO: Speaker talks use of spot vision screener on patients with developmental disability

July 18, 2016
More »